首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates
【24h】

Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates

机译:通过酶法去除含尿嘧啶的模板,减少基于福尔马林固定石蜡包埋的DNA的基于扩增子的大规模平行测序中的序列假象

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: Formalin-fixed, paraffin-embedded (FFPE) tissues are routinely used for detecting mutational biomarkers in patients with cancer. A previous intractable challenge with FFPE DNA in genetic testing has been the high number of artifactual single-nucleotide changes (SNCs), particularly for the detection of lowlevel mutations. Pretreatment of FFPE DNA with uracil-DNA glycosylase (UDG) can markedly reduce these C:G>T:A SNCs with a small panel of amplicons. This procedure has implications for massively parallel sequencing approaches to mutation detection from DNA. We investigated whether sequence artifacts were problematic in amplicon-based massively parallel sequencing and what effect UDG pretreatment had on reducing these artifacts. METHODS: We amplified selected amplicons from lung cancer FFPE DNAs using the TruSeq Cancer Panel. SNCs occurring at a frequency<10% were considered most likely to represent sequence artifacts and were enumerated for both UDG-treated and -untreated DNAs. RESULTS: Massively parallel sequencing of FFPE DNA samples showed multiple SNCs, predominantly C:G>T:A changes, with a significant proportion occurring above the background sequencing error (defined as 1%). UDG pretreatment markedly reduced C:G>T:A SNCs without affecting the detection of true somatic mutations. However, C:G>T:A changes within CpG dinucleotides were often resistant to the UDG treatment as a consequence of 5-methyl cytosine being deaminated to thymine rather than uracil. CONCLUSIONS: UDG pretreatment greatly facilitates the accurate discrimination of mutations in FFPE samples by use of amplicon-based approaches. This is particularly important when working with samples with low tumor purity or for the assessment of mutational heterogeneity in tumors.
机译:背景:福尔马林固定,石蜡包埋(FFPE)的组织通常用于检测癌症患者的突变生物标志物。在基因测试中,FFPE DNA先前难以解决的挑战是大量人为的单核苷酸变化(SNC),特别是对于检测低水平突变。用尿嘧啶DNA糖基化酶(UDG)预处理FFPE DNA可以显着减少带有少量扩增子的C:G> T:A SNC。此过程对于从DNA进行突变检测的大规模并行测序方法具有重要意义。我们调查了序列假象在基于扩增子的大规模并行测序中是否存在问题,以及UDG预处理对减少这些假象有何影响。方法:我们使用TruSeq Cancer Panel从肺癌FFPE DNA中扩增了选定的扩增子。频率小于10%的SNC被认为最有可能代表序列伪像,并被UDG处理和未处理的DNA枚举。结果:FFPE DNA样品的大规模平行测序显示多个SNC,主要是C:G> T:A变化,其中很大一部分发生在背景测序误差之上(定义为1%)。 UDG预处理可显着减少C:G> T:A SNC,而不会影响对真正体细胞突变的检测。然而,由于5-甲基胞嘧啶被胸腺嘧啶而不是尿嘧啶脱氨基,CpG二核苷酸中的C:G> T:A变化通常对UDG治疗有抗性。结论:UDG预处理通过使用基于扩增子的方法极大地促进了FFPE样品中突变的准确判别。当使用低肿瘤纯度的样品或评估肿瘤中的突变异质性时,这一点尤其重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号